Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

Rinske van Koningsveld(Erasmus MC), P.I.M. Schmitz(Erasmus MC), FGA van der Meché(Erasmus University Rotterdam), L. H. Visser(Erasmus MC), Jan Meulstee(Erasmus University Rotterdam), P. Doorn(Erasmus University Rotterdam)
The Lancet
January 1, 2004
10.1016/s0140-6736(03)15324-x
Cited by 370Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis